ZURAIMA CALDERA: Open Payments
NPI 1235457425 · CEDAR PARK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,067 in 34 payments from 11 companies in 2025. Trend: 2023 $638 · 2024 $744 · 2025 $1,067
Food & beverage: $1,067
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 3 | $386 |
| Axsome Therapeutics, Inc. | 8 | $234 |
| Otsuka America Pharmaceutical, Inc. | 8 | $143 |
| Janssen Pharmaceuticals, Inc | 2 | $64 |
| Corium, LLC | 3 | $47 |
| Noven Therapeutics, LLC | 2 | $46 |
| Collegium Pharmaceutical, Inc. | 2 | $39 |
| Lundbeck LLC | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Vertical Pharmaceuticals, LLC | 1 | $21 |
Products named: SAPIEN 3 Ultra RESILIA, Auvelity, REXULTI, SPRAVATO, Azstarys, Xelstrym, Jornay PM, TRINTELLIX.
Industry payments across TX — which companies pay providers there.
